Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
15.43
+0.28 (1.85%)
At close: Jan 7, 2026, 4:00 PM EST
15.48
+0.05 (0.32%)
After-hours: Jan 7, 2026, 6:30 PM EST
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 16 analysts that cover Wave Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $29.94, which forecasts a 94.04% increase in the stock price over the next year. The lowest target is $10 and the highest is $50.
Price Target: $29.94 (+94.04%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 7 | 8 | 8 |
| Buy | 8 | 8 | 8 | 7 | 8 | 8 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 14 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +94.43% | Dec 19, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $24 → $32 | Buy | Maintains | $24 → $32 | +107.39% | Dec 16, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $36 → $50 | Strong Buy | Maintains | $36 → $50 | +224.04% | Dec 15, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $19 → $37 | Strong Buy | Maintains | $19 → $37 | +139.79% | Dec 12, 2025 |
| Wedbush | Wedbush | Buy Maintains $20 → $33 | Buy | Maintains | $20 → $33 | +113.87% | Dec 12, 2025 |
Financial Forecast
Revenue This Year
43.02M
from 108.30M
Decreased by -60.28%
Revenue Next Year
49.90M
from 43.02M
Increased by 16.00%
EPS This Year
-1.20
from -0.70
EPS Next Year
-1.27
from -1.20
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 76.1M | 106.1M | ||||
| Avg | 43.0M | 49.9M | ||||
| Low | 32.4M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -29.7% | 146.5% | ||||
| Avg | -60.3% | 16.0% | ||||
| Low | -70.1% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.07 | -1.00 | ||||
| Avg | -1.20 | -1.27 | ||||
| Low | -1.26 | -1.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.